AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 108 filers reported holding AVROBIO INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $481,000 | -95.9% | 34,515 | -96.2% | 0.00% | -100.0% |
| Q3 2020 | $11,718,000 | -32.3% | 899,994 | -9.3% | 0.00% | -50.0% |
| Q2 2020 | $17,310,000 | +24.4% | 991,950 | +10.9% | 0.00% | 0.0% |
| Q1 2020 | $13,919,000 | -27.8% | 894,536 | -6.6% | 0.00% | 0.0% |
| Q4 2019 | $19,275,000 | +19.7% | 957,542 | -16.0% | 0.00% | 0.0% |
| Q3 2019 | $16,103,000 | +22.5% | 1,140,472 | +41.1% | 0.00% | 0.0% |
| Q2 2019 | $13,142,000 | -1.4% | 808,235 | +33.6% | 0.00% | 0.0% |
| Q1 2019 | $13,335,000 | -0.6% | 604,751 | -25.0% | 0.00% | 0.0% |
| Q4 2018 | $13,418,000 | -67.7% | 805,856 | +0.5% | 0.00% | -66.7% |
| Q3 2018 | $41,601,000 | +264.2% | 802,015 | +100.5% | 0.01% | +200.0% |
| Q2 2018 | $11,424,000 | – | 400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |